Search Results
KINECT-HD Phase III study results: valbenazine for chorea associated with Huntington’s disease
RESEARCH WEBINAR: KINECT-HD
FDA approval of valbenazine & unanswered questions in Huntington’s disease
The latest clinical trials in Huntington’s disease: valbenazine, targeting behavior, and novel DMTs
HSC x HDSA Research Webinar: Data from the Phase 3 PROOF HD Trial of Pridopidine
Keynote - HD Research Update from Dr. Claassen (Vanderbilt) - UF Huntington Disease Symposium
Research Blitz: Neurocrine, Prilenia, uniQure, Wave, Novartis, Sage, and HDClarity
Impact of Chorea in HD and the Evolving Treatment Landscape
HDSA RESEARCH WEBINAR: 2019 Year in Review
2021 Huntington's Disease Research Updates
2022 Annual Huntington's Disease Symposium | Research Update
TETRABENAZINE: Dr Dhruv Batra
